Latest Articles Page 254 of 383
-
Perspective March 28, 2022
P.1-2
J Clin Path Lab Med: 4(2): 1-2
Quantitative & quantification of ret inhibitors and kras inhibitors in mouse plasma by mass spectrometry
Author(s): Johannes Sparidans
-
Short Communication March 26, 2022
P.1-1
J Clin Path Lab Med: 4(2): 1-1
New developments in the pathology & laboratory information of retroperitoneal sarcomas.
Author(s): Manuel Beatriz
-
Mini Review March 26, 2022
P.1-2
J Clin Path Lab Med: 4(2): 1-2
Diagnosis of cardiac implantable electronic device infections by sonication process.
Author(s): Jeong Kim
-
Rapid Communication March 24, 2022
P.1-2
J Clin Path Lab Med: 4(2): 1-2
Response of covid-19 vaccination in adult hematology patients.
Author(s): Roberta Cesaro
-
Short Communication March 30, 2022
P.1-2
J Pain Manag Ther: 6(2): 1-2
The new antiepileptic tablets: Their neuropharmacology and medical symptoms.
Author(s): Clare Richmond*
-
Commentary March 28, 2022
P.1-2
J Pain Manag Ther: 6(2): 1-2
Nervous disorders across the existence path in useful resource-restricted settings.
Author(s): Edwin Caskoden*
-
Opinion Article March 24, 2022
P.1-1
J Pain Manag Ther: 6(2): 1-1
Diagnosis and treatment for the people suffering from low back pain in current times.
Author(s): Joseph Howard*
-
Perspective March 21, 2022
P.1-2
J Pain Manag Ther: 6(2): 1-2
Neuropathic pain: An overview on epidemiology, causes and distributions.
Author(s): Josephine Tey*
-
Review Article March 21, 2022
P.1-4
J Pain Manag Ther: 6(2): 1-4
The role of early pain management referral in the oncology population.
Author(s): Michelle L. Hulman*
-
Opinion Article March 30, 2022
P.1-2
Insights Nutr Metabol: 6(2): 1-2
Metabolic syndrome and its epidemiology, pathophysiology, treatment and management
Author(s): Oliver James*